
Roche has received a major boost with the first approval in early treatment of the most aggressive form of brain …
The first patient has been enrolled in a phase II trial of ICT-107, a cancer vaccine candidate for the treatment …
Early stage trials of a new treatment for the brain cancer glioblastoma multiforme have shown promise. ICT-107 is being developed …
Roche has gained US approval for Avastin in people with the aggressive brain cancer glioblastoma multiforme (GBM). The drug can …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

